Recalled Blood Thinner Unlikely to Cause Serious Harm, FDA Says
According to the U.S. Food and Drug Administration, a nationwide recall of generic dabigatran etexilate blood thinner products distributed by Major Pharmaceuticals is not expected to cause serious health harm. The federal agency classified the action as a Class III recall on August 5, indicating its lowest risk level after testing at the 12-month storage … Read more